Cancer-Associated Fibroblast-Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer.
Liang T, Tao T, Wu K, Liu L, Xu W, Zhou D, Fang H, Ding Q, Huang G, Wu S.
Adv Sci (Weinh). 2023 Nov;10(31):e2303230. doi: 10.1002/advs.202303230. Epub 2023 Sep 24.
Mesenchymal stem cells in tumor microenvironment: drivers of bladder cancer progression through mitochondrial dynamics and energy production.
Yang E, Jing S, Wang F, Wang H, Fu S, Yang L, Tian J, Golijanin DJ, El-Deiry WS, Cheng L, Wang Z.
Cell Death Dis. 2024 Sep 20;15(9):688. doi: 10.1038/s41419-024-07068-9.
Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M, Miao J, Ji Z, Lin GN, Song W, Zhang L, Bo J, Yang G, Wang J, Gao WQ.
Int J Cancer. 2021 Dec 15;149(12):2099-2115. doi: 10.1002/ijc.33794. Epub 2021 Sep 16.
CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer.
Meng X, Xiao W, Sun J, Li W, Yuan H, Yu T, Zhang X, Dong W.
Cancer Lett. 2023 Feb 1;554:216023. doi: 10.1016/j.canlet.2022.216023. Epub 2022 Nov 25.
Mesenchymal neoplasms of the urinary bladder: a comprehensive review with focus on cross-sectional imaging findings.
Balasubramanya R, Shanbhogue AK, Ramani NS, Morani AC, Khandelwal A, Prasad SR.
Abdom Radiol (NY). 2022 Aug;47(8):2881-2895. doi: 10.1007/s00261-022-03568-4. Epub 2022 Jun 15.
Mesenchymal tumours of the bladder and prostate: an update.
Tavora F, Kryvenko ON, Epstein JI.
Pathology. 2013 Feb;45(2):104-15. doi: 10.1097/PAT.0b013e32835c768b.
Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?
Molina-Cerrillo J, Martínez-Sáez O, Alonso-Gordoa T, Tirado-Zambrano P, Delgado-Vargas B, Earl J, Grande E.
Clin Genitourin Cancer. 2015 Dec;13(6):493-8. doi: 10.1016/j.clgc.2015.05.001. Epub 2015 May 13.
Origins of Bladder Cancer.
Czerniak B, Dinney C, McConkey D.
Annu Rev Pathol. 2016 May 23;11:149-74. doi: 10.1146/annurev-pathol-012513-104703. Epub 2016 Feb 22.
PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer.
Huang C, Yang Y, Wang X, Chen S, Liu Z, Li Z, Tang X, Zhang Q.
Int J Biol Sci. 2024 Jun 24;20(9):3570-3589. doi: 10.7150/ijbs.96671. eCollection 2024.
The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy.
Patwardhan MV, Mahendran R.
Int J Mol Sci. 2023 Aug 1;24(15):12311. doi: 10.3390/ijms241512311.
